Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies

Abstract Designing and carrying out a controlled human infection (CHI) model for hepatitis C virus (HCV) is critical for vaccine development. However, key considerations for a CHI model protocol include understanding of the earliest viral-host kinetic events during the acute phase and susceptibility...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenzhen Shi, Adquate Mhlanga, Yuji Ishida, Ari Josephson, Nicholson T. Collier, Hiromi Abe-Chayama, Chise Tateno-Mukaidani, Scott J. Cotler, Jonathan Ozik, Marian Major, Jordan J. Feld, Kazuaki Chayama, Harel Dahari
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83104-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559427614769152
author Zhenzhen Shi
Adquate Mhlanga
Yuji Ishida
Ari Josephson
Nicholson T. Collier
Hiromi Abe-Chayama
Chise Tateno-Mukaidani
Scott J. Cotler
Jonathan Ozik
Marian Major
Jordan J. Feld
Kazuaki Chayama
Harel Dahari
author_facet Zhenzhen Shi
Adquate Mhlanga
Yuji Ishida
Ari Josephson
Nicholson T. Collier
Hiromi Abe-Chayama
Chise Tateno-Mukaidani
Scott J. Cotler
Jonathan Ozik
Marian Major
Jordan J. Feld
Kazuaki Chayama
Harel Dahari
author_sort Zhenzhen Shi
collection DOAJ
description Abstract Designing and carrying out a controlled human infection (CHI) model for hepatitis C virus (HCV) is critical for vaccine development. However, key considerations for a CHI model protocol include understanding of the earliest viral-host kinetic events during the acute phase and susceptibility of the viral isolate under consideration for use in the CHI model to antiviral treatment before any infections in human volunteers can take place. Humanized mouse models lack adaptive immune responses but provide a unique opportunity to obtain quantitative understanding of early HCV kinetics and develop mathematical models to further understand viral and innate immune response dynamics during acute HCV infection. We show that the models reproduce the measured HCV kinetics in humanized mice, which are consistent with early acute HCV-host dynamics in immunocompetent chimpanzees. Our findings suggest that humanized mice are well-suited to support development of a CHI model. In-silico and in-vivo modeling estimates provide a starting point to characterize candidate viruses for testing in CHI model studies.
format Article
id doaj-art-4e3cd225b79340f986f392ce308ccdaf
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-4e3cd225b79340f986f392ce308ccdaf2025-01-05T12:29:31ZengNature PortfolioScientific Reports2045-23222024-12-0114111210.1038/s41598-024-83104-0Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studiesZhenzhen Shi0Adquate Mhlanga1Yuji Ishida2Ari Josephson3Nicholson T. Collier4Hiromi Abe-Chayama5Chise Tateno-Mukaidani6Scott J. Cotler7Jonathan Ozik8Marian Major9Jordan J. Feld10Kazuaki Chayama11Harel Dahari12The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University ChicagoThe Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University ChicagoPhoenixBio Co., Ltd.The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University ChicagoDecision and Infrastructure Sciences Division, Argonne National LaboratoryCenter for Medical Specialist Graduate Education and Research, Hiroshima UniversityPhoenixBio Co., Ltd.The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University ChicagoDecision and Infrastructure Sciences Division, Argonne National LaboratoryDivision of Viral Products, Center for Biologics Evaluation and Research, Food and Drug AdministrationToronto Centre for Liver Disease, Toronto General Hospital, University Health NetworkHiroshima Institute of Life SciencesThe Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University ChicagoAbstract Designing and carrying out a controlled human infection (CHI) model for hepatitis C virus (HCV) is critical for vaccine development. However, key considerations for a CHI model protocol include understanding of the earliest viral-host kinetic events during the acute phase and susceptibility of the viral isolate under consideration for use in the CHI model to antiviral treatment before any infections in human volunteers can take place. Humanized mouse models lack adaptive immune responses but provide a unique opportunity to obtain quantitative understanding of early HCV kinetics and develop mathematical models to further understand viral and innate immune response dynamics during acute HCV infection. We show that the models reproduce the measured HCV kinetics in humanized mice, which are consistent with early acute HCV-host dynamics in immunocompetent chimpanzees. Our findings suggest that humanized mice are well-suited to support development of a CHI model. In-silico and in-vivo modeling estimates provide a starting point to characterize candidate viruses for testing in CHI model studies.https://doi.org/10.1038/s41598-024-83104-0Hepatitis C virusAgent-based modelingOrdinary differential equationsLiver-humanized mouse modelControlled human infection model
spellingShingle Zhenzhen Shi
Adquate Mhlanga
Yuji Ishida
Ari Josephson
Nicholson T. Collier
Hiromi Abe-Chayama
Chise Tateno-Mukaidani
Scott J. Cotler
Jonathan Ozik
Marian Major
Jordan J. Feld
Kazuaki Chayama
Harel Dahari
Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies
Scientific Reports
Hepatitis C virus
Agent-based modeling
Ordinary differential equations
Liver-humanized mouse model
Controlled human infection model
title Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies
title_full Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies
title_fullStr Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies
title_full_unstemmed Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies
title_short Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studies
title_sort theoretical modeling of hepatitis c acute infection in liver humanized mice support pre clinical assessment of candidate viruses for controlled human infection studies
topic Hepatitis C virus
Agent-based modeling
Ordinary differential equations
Liver-humanized mouse model
Controlled human infection model
url https://doi.org/10.1038/s41598-024-83104-0
work_keys_str_mv AT zhenzhenshi theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT adquatemhlanga theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT yujiishida theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT arijosephson theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT nicholsontcollier theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT hiromiabechayama theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT chisetatenomukaidani theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT scottjcotler theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT jonathanozik theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT marianmajor theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT jordanjfeld theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT kazuakichayama theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies
AT hareldahari theoreticalmodelingofhepatitiscacuteinfectioninliverhumanizedmicesupportpreclinicalassessmentofcandidatevirusesforcontrolledhumaninfectionstudies